ARCHIVES

Carcinogenesis Testing Moved Out of DCCP To New Status As Division, Giving Rall More Authority

This article is from The Cancer Letter archive.

Vol. 05 No. 37 | September 14, 1979

Download PDF Visit The Full Archive

Related Articles

Komen Foundation Offer Fellowships

February 9, 1996

Patients Advocates Develop Statement On Health Care Reform

March 12, 1993

NCI Clarifies IRPG Application Receipt, Funding Policies

September 3, 1993

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

January 10, 2003

In Brief: DCBD Board Adds Concept Review To Duties, Rabson Seeks Four Additional Member

September 19, 1980